These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 16759053

  • 1. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM, Lassalle R, Capeau J, Bach-Ngohou K, Nazih-Sanderson F, Rémy G, Reynes J, Ecobichon JL, Savès M, Raffi F, Aproco-Copilote Study Group.
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
    Badiou S, Thiebaut R, Aurillac-Lavignolle V, Dabis F, Laporte F, Cristol JP, Mercie P, Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
    J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
    [Abstract] [Full Text] [Related]

  • 4. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
    Tarr PE, Taffé P, Bleiber G, Furrer H, Rotger M, Martinez R, Hirschel B, Battegay M, Weber R, Vernazza P, Bernasconi E, Darioli R, Rickenbach M, Ledergerber B, Telenti A, Swiss HIV Cohort Study.
    J Infect Dis; 2005 May 01; 191(9):1419-26. PubMed ID: 15809899
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan 01; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 6. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C, Gharakhanian S, Salhi Y, Nguyen TH, Chevenne D, Capeau J, Rozenbaum W.
    Diabetes Metab; 1999 Sep 01; 25(3):225-32. PubMed ID: 10499191
    [Abstract] [Full Text] [Related]

  • 7. Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy.
    Bonnet E, Ruidavets JB, Tuech J, Ferrières J, Collet X, Fauvel J, Massip P, Perret B.
    J Clin Endocrinol Metab; 2001 Jan 01; 86(1):296-302. PubMed ID: 11232015
    [Abstract] [Full Text] [Related]

  • 8. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D, Weber R, Enseleit F, Lüscher TF.
    Herz; 2005 Sep 01; 30(6):472-80. PubMed ID: 16170677
    [Abstract] [Full Text] [Related]

  • 9. Lack of association between dyslipidemia and insulin resistance in HIV-infected persons treated with highly active antiretroviral therapy.
    Swanson B, Keithley JK, Zeller JM, Sha BE.
    Nutrition; 2004 Sep 01; 20(11-12):1022-5. PubMed ID: 15561494
    [Abstract] [Full Text] [Related]

  • 10. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors.
    Martínez E, Domingo P, Ribera E, Milinkovic A, Arroyo JA, Conget I, Pérez-Cuevas JB, Casamitjana R, de Lazzari E, Bianchi L, Montserrat E, Roca M, Burgos R, Arnaiz JA, Gatell JM.
    Antivir Ther; 2003 Oct 01; 8(5):403-10. PubMed ID: 14640387
    [Abstract] [Full Text] [Related]

  • 11. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR, Lee DM, Donaldson DL, Fesmire JD, Chan WY, Holcombe JH, Rennert OM.
    Pediatr Res; 1984 Sep 01; 18(9):864-70. PubMed ID: 6483510
    [Abstract] [Full Text] [Related]

  • 12. Increased serum lipids are associated with higher CD4 lymphocyte count in HIV-infected women.
    Floris-Moore M, Howard AA, Lo Y, Arnsten JH, Santoro N, Schoenbaum EE.
    HIV Med; 2006 Oct 01; 7(7):421-30. PubMed ID: 16925727
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial DNA haplogroups and highly active antiretroviral therapy-related lipodystrophy.
    Nasi M, Guaraldi G, Orlando G, Durante C, Pinti M, Nemes E, Nardini G, Passarino G, Cocchi M, Esposito R, Mussini C, Cossarizza A.
    Clin Infect Dis; 2008 Oct 01; 47(7):962-8. PubMed ID: 18752438
    [Abstract] [Full Text] [Related]

  • 14. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.
    Antivir Ther; 2007 Oct 01; 12(2):195-203. PubMed ID: 17503662
    [Abstract] [Full Text] [Related]

  • 15. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
    Guaraldi G, Ventura P, Garlassi E, Orlando G, Squillace N, Nardini G, Stentarelli C, Zona S, Marchini S, Moriondo V, Tebas P.
    HIV Med; 2009 Jan 01; 10(1):28-34. PubMed ID: 19125962
    [Abstract] [Full Text] [Related]

  • 16. Lipodystrophy in HIV-infected pediatric patients receiving protease inhibitors.
    Temple ME, Koranyi KI, Nahata MC.
    Ann Pharmacother; 2003 Sep 01; 37(9):1214-8. PubMed ID: 12921501
    [Abstract] [Full Text] [Related]

  • 17. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I, Abrão EP, Mikawa AY, Landgraf VO, da Costa PI.
    Clin Chem Lab Med; 2004 May 01; 42(5):525-32. PubMed ID: 15202789
    [Abstract] [Full Text] [Related]

  • 18. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.
    Clin Ther; 2007 Jul 01; 29(7):1448-55. PubMed ID: 17825696
    [Abstract] [Full Text] [Related]

  • 19. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM, Zhang L, Qiu ZF, Xie J, Han Y, Yu W, Li M, Li TS.
    Zhonghua Yi Xue Za Zhi; 2009 Apr 07; 89(13):867-71. PubMed ID: 19671283
    [Abstract] [Full Text] [Related]

  • 20. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
    Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB.
    J Med Virol; 2008 Feb 07; 80(2):209-16. PubMed ID: 18098145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.